Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ludovica Scucchi
Observed names:
L Scucchi,
L. Scucchi,
Scucchi, Ludovica
Institution:
University of Rome Tor Vergata
Observed institutions:
University of Rome Tor Vergata,
Humanitas University,
Policlinico Tor Vergata,
IRCCS Humanitas Research Hospital,
Aziende Socio Sanitaria Territoriale Rhodense
ORCID:
0000-0002-3755-9102
Observed ORCID:
0000-0002-3755-9102
OpenAlex ID:
A5006307119
An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors
2022
·
Sara Onali
, Daniela Pugliese
, et al.
·
The American Journal of Gastroenterology
·
57
Histological scores in inflammatory bowel disease
2020
·
Benedetto Neri
, Michelangela Mossa
, et al.
·
Journal of Digestive Diseases
·
52
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care
2020
·
Simone Saibeni
, Ludovica Scucchi
, et al.
·
United European Gastroenterology Journal
·
19
PDF
Diagnostic yield of small bowel capsule endoscopy in obscure gastrointestinal bleeding: a real-world prospective study
2021
·
Samanta Romeo
, Benedetto Neri
, et al.
·
Internal and Emergency Medicine
·
18
PDF
IBD Flare in the COVID-19 Pandemic: Therapy Discontinuation Is to Blame
2022
·
Cristina Bezzio
, Gionata Fiorino
, et al.
·
Inflammatory Bowel Diseases
·
14
PDF
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS‐CoV‐2 infection: an IG‐IBD study
2021
·
Cristina Bezzio
, Alessandro Armuzzi
, et al.
·
Alimentary Pharmacology & Therapeutics
·
14
PDF
Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease.
2021
·
L Scucchi
, B Neri
, et al.
·
PubMed
·
9
Effect of Vedolizumab on Anemia of Chronic Disease in Patients with Inflammatory Bowel Diseases
2020
·
Patrizio Scarozza
, Elena De Cristofaro
, et al.
·
Journal of Clinical Medicine
·
8
PDF
SARS-CoV-2 Igg seroprevalence in IBD patients treated with biologics: first vs. second pandemic wave in a prospective study.
2022
·
M Mossa
, B Neri
, et al.
·
PubMed
·
7
Hepatic follicular lymphoma in an old patient with Crohn's disease: a rare case and review of the literature.
2020
·
L Scucchi
, B Neri
, et al.
·
PubMed
·
5
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves
2023
·
Cristina Bezzio
, Marta Vernero
, et al.
·
BMC Gastroenterology
·
2
PDF
T.06.8 Comparative Objective Effectiveness of Vedolizumab and Ustekinumab in a Real-life Cohort of Active Crohn’s Disease Patients Failure to Tnf Inhibitors
2022
·
S. Onali
, D. Pugliese
, et al.
·
Digestive and Liver Disease
P150 Increased risk of ibd flare after sars-cov-2 infection. who’s the more guilty: viral infection or therapy withdrawal?
2022
·
C Bezzio
, A D Guarino
, et al.
·
Journal of Crohn s and Colitis
P613 Comparative objective effectiveness of vedolizumab and ustekinumab in a real-life cohort of active Crohn’s disease patients failure to TNF inhibitors
2022
·
S Onali
, D Pugliese
, et al.
·
Journal of Crohn s and Colitis
PDF
P268 IBD and Covid-19 in italy: comparisons between first and second pandemic wave
2022
·
C Bezzio
, S Costa
, et al.
·
Journal of Crohn s and Colitis
Show more works
View as search
Works count:
20
Citation count:
205
H-index:
8
I10-index:
6
Year
Topic
Type